ReviewChemistryOpen2022
Recent Advances in the Applications of Water-soluble Resorcinarene-based Deep Cavitands.
Review in ChemistryOpen, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 22 citations in OpenAlex.
- Mandelic Acid-Mediated Enantiomeric Enrichment of a Resorcinarene-Based Dissymmetric Coordination Capsule.Chemistry, an Asian journal · 2026Article
- Construction of Well-Defined Yet Adaptable Oligo(Amino Acid) Cavities within an Aromatic Micelle.Journal of the American Chemical Society · 2026Article
- Acridane[4]Arenes: Scope of the Macro-Tetramerization, Derivatization Options, and Water-Soluble Derivatives.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- Computational Study of Alkyne-Acid Cycloisomerization in Gold-Functionalized Resorcinarene Cavitand.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Reactivity Inside Molecular Flasks: Acceleration Modes and Types of Selectivity Obtainable.Angewandte Chemie (International ed. in English) · 2024Review
- Calix[2]azolium[2]benzimidazolone hosts for selective binding of neutral substrates in water.Nature communications · 2024Article
- Window[1]resorcin[3]arenes: A Novel Macrocycle Able to Self-Assemble to a Catalytically Active Hexameric Cage.JACS Au · 2024Article
- Structural characterization of the supra-molecular complex between a tetra-quinoxaline-based cavitand and benzo-nitrile.Acta crystallographica. Section E, Crystallographic communications · 2024Article
- Thermally-induced atropisomerism promotes metal-organic cage construction.Nature communications · 2023Article
- Selective Metal-ion Complexation of a Biomimetic Calix[6]arene Funnel Cavity Functionalized with Phenol or Quinone.Chemistry (Weinheim an der Bergstrasse, Germany) · 2023Article
- Recent Advances in the Applications of Water-soluble Resorcinarene-based Deep Cavitands.ChemistryOpen · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We review here the use of container molecules known as cavitands for performing organic reactions in water. Central to these endeavors are binding forces found in water, and among the strongest of these is the hydrophobic effect. We describe how the hydrophobic effect can be used to drive organic molecule guests into the confined space of cavitand hosts. Other forces participating in guest binding include cation-π interactions, chalcogen bonding and even hydrogen bonding to water involved in the host structure. The reactions of guests take advantage of their contortions in the limited space of the cavitands which enhance macrocyclic and site-selective processes. The cavitands are applied to the removal of organic pollutants from water and to the separation of isomeric guests. Progress is described on maneuvering the containers from stoichiometric participation to roles as catalysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.